ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,277,000 | -57.0% | 1,446,142 | -47.7% | 0.02% | -48.6% |
| Q1 2022 | $200,852,000 | -13.7% | 2,765,793 | -0.0% | 0.04% | -5.4% |
| Q4 2021 | $232,664,000 | -6.8% | 2,766,844 | -0.0% | 0.04% | -14.0% |
| Q3 2021 | $249,543,000 | -5.4% | 2,766,861 | -0.0% | 0.04% | -4.4% |
| Q2 2021 | $263,824,000 | -16.3% | 2,766,905 | 0.0% | 0.04% | -22.4% |
| Q1 2021 | $315,040,000 | -27.3% | 2,766,905 | -11.6% | 0.06% | -30.1% |
| Q4 2020 | $433,248,000 | +62.8% | 3,129,724 | -3.3% | 0.08% | +43.1% |
| Q3 2020 | $266,087,000 | +5.1% | 3,237,461 | +0.0% | 0.06% | -4.9% |
| Q2 2020 | $253,230,000 | +76.1% | 3,237,413 | +0.0% | 0.06% | +45.2% |
| Q1 2020 | $143,837,000 | +4.0% | 3,237,381 | +0.0% | 0.04% | +35.5% |
| Q4 2019 | $138,265,000 | +36.3% | 3,237,295 | +36.5% | 0.03% | +29.2% |
| Q3 2019 | $101,450,000 | -14.6% | 2,371,430 | +26.8% | 0.02% | -14.3% |
| Q2 2019 | $118,781,000 | -5.3% | 1,870,572 | +3.4% | 0.03% | -6.7% |
| Q1 2019 | $125,430,000 | +82.2% | 1,808,390 | +14.2% | 0.03% | +57.9% |
| Q4 2018 | $68,846,000 | -38.3% | 1,583,390 | +8.3% | 0.02% | -29.6% |
| Q3 2018 | $111,563,000 | +74.6% | 1,461,390 | +75.8% | 0.03% | +92.9% |
| Q2 2018 | $63,902,000 | +145.7% | 831,302 | +63.0% | 0.01% | +133.3% |
| Q1 2018 | $26,005,000 | +9.9% | 510,000 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $23,654,000 | +9.7% | 510,000 | +25.9% | 0.01% | 0.0% |
| Q3 2017 | $21,570,000 | +65.4% | 405,000 | +92.9% | 0.01% | +66.7% |
| Q2 2017 | $13,043,000 | +32.7% | 210,000 | +44.8% | 0.00% | +50.0% |
| Q1 2017 | $9,828,000 | +25.1% | 145,000 | +107.1% | 0.00% | 0.0% |
| Q4 2015 | $7,853,000 | +16.5% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,742,000 | -5.9% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $7,167,000 | -20.4% | 70,000 | -51.7% | 0.00% | 0.0% |
| Q1 2015 | $9,003,000 | -43.3% | 145,000 | -59.9% | 0.00% | -50.0% |
| Q4 2014 | $15,884,000 | -22.5% | 361,987 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $20,488,000 | +26.1% | 361,987 | 0.0% | 0.01% | +50.0% |
| Q2 2014 | $16,250,000 | -8.2% | 361,987 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $17,698,000 | – | 361,987 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |